Easywell Biomedicals, Inc. (TPEX:1799)
Taiwan
· Delayed Price · Currency is TWD 31.90
-0.25 (-0.78%)
At close: Feb 26, 2026
Easywell Biomedicals Revenue
Easywell Biomedicals had revenue of 174.43M TWD in the quarter ending September 30, 2025, a decrease of -8.42%. This brings the company's revenue in the last twelve months to 588.89M, up 21.72% year-over-year. In the year 2024, Easywell Biomedicals had annual revenue of 540.44M with 98.96% growth.
Revenue (ttm)
588.89M
Revenue Growth
+21.72%
P/S Ratio
6.75
Revenue / Employee
n/a
Employees
n/a
Market Cap
3.98B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 540.44M | 268.81M | 98.96% |
| Dec 31, 2023 | 271.63M | 92.73M | 51.83% |
| Dec 31, 2022 | 178.90M | -18.38M | -9.32% |
| Dec 31, 2021 | 197.28M | -70.38M | -26.29% |
| Dec 31, 2020 | 267.65M | -92.31M | -25.64% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Orient EuroPharma | 4.53B |
| Merdury Biopharmaceutical | 246.00K |
| Maywufa Company | 1.55B |
| PhytoHealth | 138.46M |
| LIWANLI Innovation | 118.93M |
| Johnson Chemical Pharmaceutical Works | 567.06M |
| SCI Pharmtech | 1.39B |
| Orient Pharma | 1.28B |